ELEKTA ANNOUNCES ELEKTA INFINITY - A NEW SYSTEM FOR FASTER AND MORE PRECISE TREATMENT OF CANCER TUMORS

ELEKTA ANNOUNCES ELEKTA INFINITY - A NEW SYSTEM FOR FASTER AND MORE PRECISE
TREATMENT OF CANCER TUMORS

PRESS RELEASE	
Stockholm, Sweden, October 29, 2007

Elekta, a global leader in radiation oncology and non-invasive neurosurgery
solutions, announced Elekta Infinity*, the definitive new digital linear
accelerator optimized for delivering Volumetric Intensity Modulated Arc Therapy*
(VMAT), a very fast Intensity Modulated Radiation Therapy (IMRT) treatment
delivered in single or multiple arcs, at the 49th Annual Meeting of The American
Society for Therapeutic Radiology and Oncology (ASTRO). The meeting is being
held October 28-November 1, at the Los Angeles Convention Center.

In the Elekta booth, Jay Hoey, Executive Vice President Product Creation at
Elekta and CEO of IMPAC Medical Systems, announced the new Elekta Infinity,
which more precisely targets tumors and protects surrounding healthy tissue,
while drastically reducing radiation therapy treatment times. 

“Elekta is committed to fighting serious disease and improving quality of life,”
says Hoey. “The Elekta Infinity with VMAT demonstrates this by benefiting
patients with dramatically shorter treatment times and highly precise tumor
targeting.”

Elekta VMAT improves on IMRT technology

Utilizing Elekta's VMAT solution greatly improves on existing IMRT technologies
and offers a faster alternative to helical tomotherapy. Elekta's VMAT solution,
when used with Elekta Infinity, varies the radiation beam during treatment by
simultaneously manipulating the gantry position and speed, MLC leaves, dose rate
and collimator angle. 

This provides several distinct advantages over current IMRT techniques,
specifically the ability to deliver more radiation to the target while sparing
healthy tissue in significantly less time than existing therapies. In addition,
Elekta Infinity combines VMAT with VolumeView™ 3D cone beam imaging to create
high-contrast images with ultra-low dose. 

Patients benefit from faster treatments, reduced radiation

Elekta Infinity allows for a total VMAT treatment session in no more than five
minutes, including true VolumeView™ 3D cone beam images in three minutes and two
minutes of highly conformal arc delivery of radiation. Head and neck treatments
- including daily 3D imaging - can be delivered in less than five minutes with
Elekta Infinity. Coupled with the Elekta Infinity system's clinically proven
ultra-low 3D imaging dose, the speed of VMAT treatments can reduce the whole
body dose of patients receiving treatment. Elekta Infinity also protects
patients with real-time control point to control point monitoring throughout the
process.

Due to the ability of Elekta Infinity to also treat in non-coplanar angles and
non trans-axial planes, the system can yield similar or improved dosimetric
performance compared to helical tomotherapy.

More solutions from Elekta

In addition to Elekta Infinity, Elekta is exhibiting other solutions for
boosting clinical efficiency at ASTRO. Elekta's complete stereotactic portfolio
is featured, as well as innovative and time-saving products from the Elekta
Group. 


******





*Elekta Infinity and Volumetric Intensity Modulated Arc Therapy (VMAT) from
Elekta are works in progress and not yet available for sale or distribution

For further information, please contact:

Media inquiries: Michelle Lee, PR and Advertising Manager, Tel: +1 770-670-2447,

e-mail: michelle.lee@elekta.com

Global Marketing inquiries: Peter J. Gaccione, Vice President, Global Marketing,
Tel:  +1 770-670-2380, e-mail: peter.gaccione@elekta.com

Investor inquiries: Peter Ejemyr, Group VP Corporate Communications, Tel: +46
733 611 000 (mobile), e-mail: peter.ejemyr@elekta.com  

About Elekta

Elekta is an international medical technology group, providing oncologists,
radiation therapists, neurosurgeons and many other medical specialists with
state of the art tools to fight serious disease.

Elekta provides advanced clinical solutions, comprehensive management and
information systems as well as services for improved cancer care and management
of brain disorders. 

Elekta's systems and solutions are used in over 4,500 hospitals around the
world. Clinical and information management solutions include, among others,
Leksell Gamma Knife® for non-invasive treatment of brain disorders, Elekta
Axesse™ and Elekta Synergy® for stereotactic and image guided radiation therapy
and radiosurgery as well as the MOSAIQ™ suite of software for image-enabled EMR
and efficient management of clinical and patient data.

With over 2,000 employees globally, the corporate headquarter is located in
Stockholm, Sweden and the company is listed on the Nordic Exchange under the
ticker EKTAb. More information about Elekta can be found at www.elekta.com.